Does UPADACITINIB Cause Product residue present? 442 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 442 reports of Product residue present have been filed in association with UPADACITINIB (Rinvoq). This represents 0.7% of all adverse event reports for UPADACITINIB.
442
Reports of Product residue present with UPADACITINIB
0.7%
of all UPADACITINIB reports
0
Deaths
52
Hospitalizations
How Dangerous Is Product residue present From UPADACITINIB?
Of the 442 reports, 52 (11.8%) required hospitalization.
Is Product residue present Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 442 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Product residue present?
LEVODOPA (534)
ESTRADIOL (225)
POTASSIUM (183)
BUDESONIDE (168)
MESALAMINE (156)
MINOXIDIL (151)
FEXOFENADINE\PSEUDOEPHEDRINE (149)
TOFACITINIB (130)
BUPROPION (123)
METFORMIN (122)
Which UPADACITINIB Alternatives Have Lower Product residue present Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL